Treace Medical Concepts (TMCI) Change in Acquisitions & Divestments (2022 - 2026)

Treace Medical Concepts (TMCI) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $11.3 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 32.39% year-over-year to $11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $61.9 million (down 37.39% YoY) and the FY2025 annual result came in at $67.3 million, down 43.2% from the prior year.
• Change in Acquisitions & Divestments retreated to $11.3 million in Q1 2026, from $17.7 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $37.0 million in Q4 2023 to a low of $1.7 million in Q4 2022.
• A 5-year average of $22.8 million and a median of $22.4 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments soared 2042.57% — and 2025, when it tumbled 54.01%.
• Tracing TMCI's Change in Acquisitions & Divestments over 5 years: stood at $1.7 million in 2022, then soared by 2042.57% to $37.0 million in 2023, then slumped by 32.02% to $25.2 million in 2024, then declined by 29.53% to $17.7 million in 2025, then sank by 36.23% to $11.3 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $11.3 million (Q1 2026), $17.7 million (Q4 2025), and $16.2 million (Q3 2025), per Business Quant data.